Pharmacogenetic panel decreases medication-related adverse events in adults

Question clinique

Can pharmacogenetic testing decrease adverse events for new drugs prescribed to adults?

L’Essentiel

In this large multinational study, 12-gene pharmacogenetic testing resulted in a modest reduction in overall adverse events but had an unclear effect on serious adverse events. 1b-

Plan de l'etude: Randomized controlled trial (nonblinded)

Financement: Government

Cadre: Other

Reviewer

Henry C. Barry, MD, MS
Professor
Michigan State University
East Lansing, MI


Discutez de ce POEM


Commentaires

ARUP KUMAR DHARA

Impact assessment

Excellent

Anonymous

Not ready for prime time

This may be better in time, but not yet